|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
2
|
|
pubmed:dateCreated |
1992-4-3
|
|
pubmed:abstractText |
While lithium is effective in treating the majority of bipolar patients during a manic episode, the addition of neuroleptic during the early phase of treatment has been common clinical practice in inpatient settings. In an earlier open study, we demonstrated the utility of the short-acting benzodiazepine lorazepam as an adjunct to lithium for the clinical management of manic agitation.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Feb
|
|
pubmed:issn |
0160-6689
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
53
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
47-52
|
|
pubmed:dateRevised |
2006-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:1541605-Adult,
pubmed-meshheading:1541605-Aged,
pubmed-meshheading:1541605-Aggression,
pubmed-meshheading:1541605-Bipolar Disorder,
pubmed-meshheading:1541605-Double-Blind Method,
pubmed-meshheading:1541605-Drug Therapy, Combination,
pubmed-meshheading:1541605-Female,
pubmed-meshheading:1541605-Haloperidol,
pubmed-meshheading:1541605-Humans,
pubmed-meshheading:1541605-Lithium,
pubmed-meshheading:1541605-Lorazepam,
pubmed-meshheading:1541605-Male,
pubmed-meshheading:1541605-Middle Aged,
pubmed-meshheading:1541605-Psychiatric Status Rating Scales,
pubmed-meshheading:1541605-Psychomotor Agitation
|
|
pubmed:year |
1992
|
|
pubmed:articleTitle |
Adjunctive treatment of manic agitation with lorazepam versus haloperidol: a double-blind study.
|
|
pubmed:affiliation |
Department of Psychiatry, University of Vermont College of Medicine, Burlington 05405.
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Comparative Study,
Randomized Controlled Trial
|
